Brad is a partner in the Philadelphia office of LMP. He joined the firm in 2009. Prior to LMP, Brad was part of the Financial Institutions Group at Bank of America Merrill Lynch, where he focused on M&A and capital raising transactions for the firm’s investment banking clients. Previously, Brad was an Assistant Vice President in Bank of America’s Finance Group. Brad began his career in a strategic advisory group within Wachovia Corporation.

Brad is currently a member of the Boards of Directors of Omni Healthcare Financial, Pathstone, SRS Acquiom, and TortoiseEcofin, and previously served on the boards of Commercial Credit Inc., First Allied Holdings Inc. and LSQ Funding. Brad received an M.B.A. with a concentration in Finance and Accounting from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Business Administration from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.

Amandine joined Eurazeo in 2010. From 2007 to 2010, Amandine Ayrem began her career within the investment banking team of Deutsche Bank in Paris. She has been involved in a number of French and cross-border M&A transactions for European industrial and financial sponsor clients. Amandine is specialised in Consumer Goods, Ingredients and Healthcare industries (Life sciences and Consumer).

Since joining, Amandine has participated in the structuring or the monitoring of the Europcar, Foncia, Les Petits Chaperons Rouges, CPK, Iberchem and DORC investments. She also contributed to the disposal of Foncia and to the partial exit strategy of Europcar including the 2015 IPO and ABB placement. She currently serves on the boards of DORC and CPK.

She was awarded a ‘2018 Grand Prix’ by France Invest in their first set of awards honoring excellence among women private equity professionals.

Amandine graduated from HEC Paris in Finance and from Columbia Business School Executive Program.

Andrew Bab is a corporate partner, member of the firm’s Mergers & Acquisitions and Private Equity Groups, and Co-Head of the Healthcare & Life Sciences Group. Mr. Bab has worked extensively on public and private acquisitions, divestitures and joint ventures, including cross-border transactions for both private equity and corporate clients, as well as licensing arrangements and other corporate transactions. He has experience across many industries, but is particularly active in the healthcare sector. In addition, he frequently advises Deutsche Bank, Guggenheim Securities, J.P. Morgan Securities, Morgan Stanley and other investment banks on major M&A transactions. Mr. Bab led The Deal’s “Private Equity Deal of the Year” for representing TPG Capital and Welsh, Carson, Anderson & Stowe, together with Humana, in their $4.1 billion acquisition of Kindred Healthcare.

Ge Bai, PhD, CPA is an associate professor of Accounting at Johns Hopkins Carey Business School and associate professor of Health Policy & Management (joint) at Johns Hopkins Bloomberg School of Public Health. She is an expert on health care pricing, policy, and management. Dr. Bai has testified before House Ways and Means Committee, written for the Wall Street Journal, and published her studies in leading academic journals such as the New England Journal of Medicine, JAMA, JAMA Internal Medicine, Annals of Internal Medicine, and Health Affairs. Her work has been widely featured in ABC, CBS, CNN, Fox News, Los Angeles Times, NBC, New York Times, NPR, the Wall Street Journal, Washington Post, and other media and used in government regulations and congressional testimonies.

Vinay Bhupathy is a partner in the Corporate Practice Group in Sheppard Mullin’s Century City office and a member of the national Healthcare Team. Vinay specializes in healthcare innovation and brings a deep understanding of healthcare from his biomedical engineer background. He provides comprehensive counseling to healthcare clients across a broad range of issues, including complex joint ventures and mergers and acquisitions, value-based care and reimbursement and regulatory compliance, health information technology contracting, product development and operations, data security and privacy (including HIPAA compliance), fraud and abuse laws, corporate practice of medicine and healthcare licensure and certification. He regularly assists providers with navigating the complex issues surrounding CMS innovation models and has unique expertise in helping healthcare entities establish vertically integrated joint ventures across the healthcare spectrum. Vinay also assists healthcare technology companies – especially health information technology companies and mobile app developers – with regulatory compliance throughout the product life cycle, from product development to post-market compliance. His practice extends to contract drafting and negotiation for managed care companies, insurers, hospitals, health systems, physicians, ancillary providers and vendors.

Christian Chauvet is a Principal at Lee Equity Partners LLC. Mr. Chauvet joined Lee Equity in 2014 and helps lead the firm’s investments in behavioral health and provider services. Prior to joining Lee Equity, Mr. Chauvet was a consultant at McKinsey & Company in New York.

Within behavioral health, Mr. Chauvet has been privileged to work with Eating Recovery Center, the country’s foremost center for the in‐patient treatment of anorexia and bulimia, as well as Summit Behavioral Health, a leading residential substance abuse provider with over 1,500+ licensed beds across 22 campuses nationwide. In addition to investments in behavioral health, Mr. Chauvet has helped to execute purchase/sale transactions for leading healthcare companies such as Solaris Health, the leading urology practice in the country, Prelude Fertility, the largest network of owned fertility centers in the U.S., and PDR Network, a leading physician and patient education platform.

Mr. Chauvet earned his BA from Harvard College, with magna cum laude honors.

Ben joined GTCR in 2008 and is currently a Managing Director of the firm. Prior to joining GTCR, he worked as a Venture Capitalist at Alta Partners, as well as an Investment Banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in history magna cum laude from Colgate University. Ben also holds a master’s degree in biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania.

He is currently a Director of Albany Molecular Research, Antylia Scientific, Corza Health, Maravai LifeSciences and TerSera. Ben was previously a Director of past GTCR investments including Actient Pharmaceuticals, Cord Blood Registry, Crealta Pharmaceuticals, Devicor Medical Products, GeneraMedix, Sterigenics and XIFIN. In addition, Ben was involved in transactions with past GTCR investments ATI Physical Therapy and Graceway Pharmaceuticals.

Ben is active in the community and serves on the executive board of Spark Program, a national non-profit that provides transformative apprenticeships for at-risk middle-school students.

Mr. Evans is a Managing Director and Head of Healthcare Finance of Monroe Capital. He is responsible for relationship sourcing and the origination of new business opportunities within the healthcare industry. Mr. Evans has over 19 years of experience in healthcare finance. Prior to Monroe, he was at Principal at Beverly Capital, a healthcare focused private equity firm. He was formerly a Vice President in the Healthcare Leveraged Finance group at Madison Capital where he originated, structured and underwrote debt financing for private equity sponsored transactions. Prior to Madison Capital, Mr. Evans worked in Merrill Lynch Capital Healthcare Finance’s leveraged lending group. He earned his M.B.A. from the Northwestern University’s Kellogg School of Management and his B.A. in Economics from the University of Michigan.

Adam is the Managing Partner at Vesey Street Capital Partners, a leading middle market Private Equity firm focused on the healthcare sector. In addition to being a Board Member of several Healthcare Services companies, he is also the Chairman of the Board of Directors of HealthChannels (ScribeAmerica), Elite Body Sculpture and QualityMetric. He is also a board member at PathGroup and previously served on the boards of Imedex and Surgery Partners. Prior to founding VSCP, he was the Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at Laboratory Corporation of America Holdings (LabCorp) where he oversaw M&A, and Corporate Development. He also created the LabCorp private equity investment vehicle.

Prior to LabCorp, Adam was the Managing Director in Equity Research at Barclays Capital/Lehman Brothers for 14 years, where he covered, the firm’s Health Care Facilities and Services research teams. He was ranked #1 in the Institutional Investor (II) All America Research Survey in the Health Care Facilities category for over a decade. Mr. Feinstein has a B.S. in Business from the Smith School at the University of Maryland at College Park. He also completed the Nashville Healthcare Council Fellows program.

Michael Fisher joined Varsity Healthcare Partners in 2016. Prior to joining Varsity, Mr. Fisher was a Vice President at Enhanced Equity Funds, a lower middle-market, healthcare-focused private equity firm. Mr. Fisher began his career in the healthcare investment banking group of Cowen and Company. He graduated from the University of Richmond with a BS in Business Administration and Concentrations in Finance and Economics. Mr. Fisher currently serves on the Board of Directors for Angels of Care.

Alexis J. Gilman is a partner in Crowell & Moring’s Antitrust Group in Washington, D.C. Alexis advises and represents clients on a broad range of civil antitrust matters, including merger reviews and clearances, government investigations, premerger Hart-Scott-Rodino (HSR) notifications, and antitrust litigation, with a particular focus on representing merging parties and third parties in merger investigations by the Federal Trade Commission, Department of Justice, and state attorneys general offices. His experience spans a wide range of industries, with a particular emphasis on healthcare mergers and acquisitions. Alexis was recognized by Who’s Who Legal in the category Competition Future Leaders – Partners in 2019 and 2020, as a Recommended Lawyer by Legal 500 in the category Antitrust: Merger Control in 2020, and by Best Lawyers in America 2021 for Antitrust.

From 2014-2017, Alexis served as the Assistant Director of the Mergers IV Division in the Bureau of Competition of the Federal Trade Commission, leading the 30-attorney division and working on some of the agency’s highest-profile matters in healthcare and other industries. Prior to this position, Alexis served as a Deputy Assistant Director of the Mergers IV Division from 2012-2014, and a Staff Attorney in the division from 2010-2012.

Larry Gilmore is Senior Director of Corporate Development at VSP Global. Larry joined VSP in September of 2014 and reports to Eric Johannessen, Senior Vice President of Corporate Development. Corporate Development is housed under the Office of General Counsel, which is led by Thomas Fessler, the Chief Legal Officer at VSP Global.

Larry is primarily responsible for managing corporate development activities for VSP Global which is a $7B+ industry leader. Larry leads a team of industry and financial professionals who work with VSP’s corporate executives and business unit leaders to direct and implement the company’s global strategic growth goals and initiatives. The group’s activities include targeting, negotiating and completing the full lifecycle of U.S and international strategic M&A transactions, including minority non-controlling investments, to increase the company’s competitive advantage through acquisition, joint venture or strategic alliance. We primarily target vision care, eyewear brands, practice management software companies, optical labs, and retail optometry businesses. The group also secures intellectual property interests in cutting edge industry technologies.

Jordan Hamburger is a partner in the Corporate Practice Group in Sheppard Mullin’s Century City office, co-head of the firm’s Mergers and Acquisitions team, and a member of the national Healthcare Team. Jordan’s practice focuses on corporate and securities matters, including mergers and acquisitions, joint ventures and other affiliations, public and private securities offerings and general corporate representation. He represents private equity firms, corporations, not-for-profit entities, entrepreneurs, and other market participants in the healthcare and financial services industries, among others. Additionally, Jordan advises public and private companies on corporate governance matters, and represents public companies in connection with securities law compliance and reporting, including compliance with NASDAQ and NYSE listing standards.

Brian Heaphy is Vice President, Corporate Development in the Strategy and Business Development group at Bristol Myers Squibb. Brian most recently has completed over $100 Billion in transactions including the acquisitions of MyoKardia and Celgene and the divestitures of Otezla and the UPSA OTC Business. Prior to his time at Bristol Myers Squibb, Brian was the head of business development at Jefferson National Financial and previously specialized in M&A at Davis Polk & Wardwell. Brian began his career in the banking industry at JP Morgan and Goldman Sachs. He is a graduate of Queens College and Brooklyn Law School.

Mr. Kandoi is a Principal at VSS and joined the firm in 2013. He is responsible for evaluating, executing, and monitoring investments across all of VSS’s Target Industries. Mr. Kandoi currently serves as a board member of Really Great Reading and Endo1; and as a board observer of Connexion Point, Caravan Health and QuadaraNet. He previously served on the boards of VKidz and BrandShop. He has also been active in the firm’s investments in Acrisure, Coretelligent, Cambium Learning Group, Infobase Learning, and Metschools. Prior to joining VSS, Mr. Kandoi was a part of the investment banking team at Citigroup. Mr. Kandoi completed the Jerome Fisher Program in Management and Technology at the University of Pennsylvania, earning BS degrees in Economics and Computer Science from The Wharton School and the School of Engineering and Applied Science, respectively.

Andrew Kaplan joined Bain Capital in 2009 as a member of the Private Equity team. He is a Principal in the Healthcare Vertical. He has been a key contributor in the acquisitions of Air Medical, Beacon Health, National Surgical Healthcare, Stada Arzneimittel, Surgery Partners, US Renal Care, Value Options and the acquisition of assets from Healix, UPI, Bristol Myers Squibb and UnitedHealth to form the pharmaceutical services firm QuVa Pharma. Andrew currently serves on the Board of Directors of Surgery Partners, QuVa Pharma and US Renal Care, and until recently Beacon Health Options. He is also a Governing Trustee at the Dana-Farber Cancer Institute and serves as Vice Chair of the Boston Preparatory Academy’s Board of Trustees. Prior to Bain, Andrew was an investment banker with Goldman Sachs. Andrew received an MBA from Harvard Business School where he was a Baker Scholar. As an undergraduate, he attended The Wharton School at the University of Pennsylvania, where he served as Class President for four years, and graduated magna cum laude with a BS in Economics.

Mike Kaplan is an Advisory Partner at Granite Growth Health Partners and Managing Director of Altos Health, a venture capital firm he founded in 2009. He has invested in 30 companies in healthcare services, healthcare IT, and medical devices over the past 20 years. Mike’s current boards include ABS Kids (autism treatment), Latitude (food allergy clinics), and Sterling (HSA administration).

Mike was previously a Partner at Three Arch Partners, a $1.1 billion fund focused on life sciences and healthcare services. His notable investments included Free & Clear, Ascend Health, Centerre, Habit Holdings, Novacept, and Vascular Control Systems. Before joining Three Arch, Mike was an operating executive at Blue Shield of California, serving as Vice President of Corporate Development and Strategic Planning, Regional Chief Executive for Northern California, and Vice President of Business Transformation. Earlier in his career, Mike was a Senior Manager in consulting for APM/CSC Healthcare and a Financial Analyst at Kidder, Peabody & Co.

Mike earned an MBA from the Stanford Graduate School of Business and a BS in Business Administration from Washington University in St. Louis.

As a Vice President with Blue Sea Capital, Erin Lansky identifies, evaluates, and executes healthcare investment opportunities and provides ongoing support to the firm’s portfolio companies. She currently serves as a Board Member of Apex Physics Partners.

Prior to joining Blue Sea Capital, Erin was a Vice President at RoundTable Healthcare Partners, an operating-oriented healthcare private equity firm. Prior to RoundTable, Erin was a Vice President at BDT Capital Partners and an Associate on GTCR’s Healthcare team in Chicago. She began her career in the Mergers & Acquisitions Group at Bank of America Merrill Lynch in New York.

Erin received her A.B. in Economics and Spanish/Hispanic Studies from Dartmouth College, where she graduated magna cum laude and Phi Beta Kappa, with Highest Honors. In her spare time, Erin leads her Class’ alumni fundraising for the Dartmouth College Fund, which supports student financial aid, and volunteers with Minds Matter, which prepares high school students from underserved communities for college success.

James C.H. Lee is a partner in the Corporate Department and a member of our Private Equity and Mergers & Acquisitions Groups. James has extensive experience advising private equity funds, venture capital funds, private investment firms, high-net worth family offices, and their respective portfolio companies in a variety of domestic and cross border transactions, including mergers and acquisitions, leveraged buyouts, growth equity investments, AIV structure transactions, recapitalizations, reorganizations, acquisitions and divestitures, and debt and equity security investments. His transaction experience is across a targeted spectrum of industries, including healthcare (medical devices/distribution and medical services) and digital healthcare, manufacturing/aerospace, industrial, industrial-tech and distribution, advertising technology, Internet of Things, SaaS based services, internet-based products and services, fin-tech, and oil and gas supply-chain and related services.

In addition, James advises senior executives, senior advisors, boards of directors, and private equity funds on corporate governance matters, portfolio company operations and management, and executive compensation arrangements and separations.

Lenard is responsible for leading Edison investments in companies primarily located in the mid-Atlantic area. Lenard co-leads healthcare IT investments and leads Edison’s security practice. Lenard is active in the mid-Atlantic venture community serving as a board member for the Maryland Venture Fund and Greater Baltimore Technology Council.

Lenard began his career at IBM where he worked as a Financial Analyst for IBM Global Services. His main responsibilities were overseeing a budget of $80 million and partnering with international locations to decrease the project costs of IBM Global Services West. Later, Lenard worked for Princeton eCom—an online bill payment company—where, as Manager of B2C Implementations; he oversaw one of the largest joint ventures in the company’s history. Lenard later led B2C Product Development at Princeton eCom prior to earning his MBA. Lenard also worked in healthcare investment banking for Wachovia Securities.

Geoff is a Partner at Two Sigma Impact. Geoff comes to Two Sigma from Lee Equity Partners, a U.S. growth buyouts firm, where he led the firm’s healthcare investments and served as a partner and member of the firm’s Investment Committee. Prior to Lee Equity, Geoff worked in the private equity funds of TPG Capital and Bain Capital.

He began his career as a consultant at Bain & Company. Geoff was a faculty lecturer at Stanford Business School and is a member of the Board of Directors of the Healthcare Private Equity Association. Geoff has been a director of several companies, including Solaris Health, Summit BHC, Westfall Technik, Eating Recovery Centers, PDR Networks, Key Health, Paragon Industries and Axcan Pharma. Geoff earned an M.B.A. from Stanford Business School and a B.A. in Engineering Sciences, cum laude, from Dartmouth College.

Mr. Mattamana is a Partner at Fairview Capital and a member of its Investment Committee. He is involved in investment selection, deal execution and monitoring activities for Fairview’s venture capital and private equity direct co-investment and partnership portfolios. Mr. Mattamana represents Fairview on direct investments including eVariant (acquired by Healthgrades), Device42, Rallybio, Covr Financial, Inbox Health, and 365 Datacenters, and serves on a number of advisory boards of venture capital and private equity partnerships.

Prior to joining Fairview in 2009, Mr. Mattamana was a Principal with Polaris Venture Partners, a diversified venture capital firm. At Polaris, he focused on venture capital investments in the software, digital media, consumer, medical technology, and healthcare services sectors. He was involved in several successful investments including Q1 Labs, Archivas and Turbine Entertainment, and served as board observer to portfolio companies including Advion BioSciences and GI Dynamics. Previously, Mr. Mattamana was a strategy consultant at McKinsey & Co, where he served clients in the software, telecommunications and aerospace sectors in the firm’s Silicon Valley office. He also has prior experience at NASA, Goldman Sachs, and Neuberger Berman.

Ezra joined HEP in 2010, while completing his MBA at Columbia Business School. Prior to joining the team, Ezra was a Senior Analyst at the Advisory Board Company (NASDAQ: ABCO), providing best practice consulting and research services to hospitals and health systems. After leaving the Advisory Board Company, Ezra served as a Senior Consultant in the health care practice of Booz Allen Hamilton focusing on engagements in the provider space.

Ezra is currently on the board of directors of CenterPointe Behavioral Health System, Jvion, Twistle, and Wildflower Health. He previously served on the board of directors AxiaMed (acquired by Bank of America), Applied Pathways (acquired by AIM Specialty Health, a division of Anthem, Inc) and InDemand Interpreting (acquired by Stratus Video/AMN Healthcare). He sits on the Harvard School of Public Health’s Health Policy and Management Executive Council. He is on the faculty of Columbia Business School.

Ezra holds a BA cum laude from Washington University in St. Louis, and an MBA from Columbia Business School.

Steven Rodgers is a Partner of Morgan Stanley Capital Partners (MSCP). He is based in New York and has 22 years of investing experience.

Mr. Rodgers joined Morgan Stanley in 2018 from J.H. Whitney Capital Partners, where he was a Senior Managing Director focusing on private equity investments. At Whitney Mr. Rodgers was a member of the Investment Committee and led the firm’s healthcare investing activities. Mr. Rodgers was a Managing Partner at the Riverside Company, a global private equity firm, where he led the firm’s efforts to invest in public companies utilizing a private equity approach. He was also a financial analyst at Alex. Brown & Sons Incorporated.

Mr. Rodgers serves on the board of directors of Ovation Fertility, Aveanna Healthcare, 3B Scientific and Clarity Software and previously served on the board of directors of a number of other healthcare companies, including Amisys Synertech, Herbalife, Patient Keeper, and Symbion. Mr. Rodgers graduated, cum laude, from Dartmouth College, and holds an MBA from The Stanford University Graduate School of Business.

Todd D. Rosenberg is a partner in the firm’s Corporate Group. Todd’s practice focuses on mergers and acquisitions, joint ventures, equity and debt financings, and complex commercial agreements (including outsourcing agreements, service agreements, and intellectual property licensing agreements). Todd regularly advises public and private corporations, financial institutions, hedge funds, and private equity funds. Todd has significant experience with transactions in a wide-variety of industries, including healthcare, financial services, government contracts, transportation, media, technology, and telecommunications.

Todd frequently teams with members of the firm’s Health Care Group on transactions, involving payers, providers, and digital health industry participants. These transactions include pharmacy benefit management outsourcing agreements, joint ventures, the sale and acquisition of plans and related businesses, and agreements related to the establishment of accountable care organizations and other innovative care-delivery and risk sharing arrangements.

Gregory A. Schernecke focuses his practice on mergers and acquisitions, with a particular emphasis on private equity; corporate finance and general corporate matters. Mr. Schernecke represents private equity sponsors, alternative asset managers and operating companies in complex merger and acquisition transactions across a wide range of industry sectors, including healthcare and life sciences. He also represents companies and investment banks in cross border public and private financing transactions and securities offerings of equity and debt.

Mr. Searby is a managing director at Thomas H. Lee Partners. Mr. Searby is responsible for Business Development, including sourcing strategy, market-facing relationships and development of Identified Sector Opportunities in the Healthcare and Technology & Business Services industry groups. In these roles, Mr. Searby brings significant technology related industry experience in the areas of consumer technology, e-commerce, software and tech-enabled business services.

Prior to joining Thomas H. Lee Partners, Mr. Searby was a Senior Vice President in corporate development with MyWebGrocer, the only end-to-end Digital Experience Platform for leading grocers and CPG brands, where he was responsible for corporate strategy and executive oversight of capital markets activities. He also played a key role as Senior Vice President of strategic initiatives at the same company, providing management oversight of digital marketing strategy and sales. Mr. Searby previously served on the board of directors of NorthCounty Credit Union and worked in investment management at CitiGroup.

Mr. Searby holds a B.A. in History from University of Vermont.

Alissa is a Senior Associate at Lorient where she focuses on the evaluation and execution of potential investments in addition to leading operational initiatives within existing portfolio companies.

Prior to joining Lorient, Alissa worked in Corporate Development at Humana and was responsible for conducting due diligence on new investment opportunities as well as aligning potential investments with Humana’s strategic initiatives. Previously, Alissa worked with Covington Associates, a boutique, healthcare-focused investment bank in Boston, MA where she led sell-side diligence and go-to-market initiatives. Before Covington, Alissa worked in Corporate Development at MEDNAX Health Solutions in South Florida. While at MEDNAX, Alissa facilitated multiple acquisitions of hospital-based, specialty clinician practices nationwide. Alissa graduated from Bentley University in Waltham, MA with a BS in Corporate Finance and Accounting.

Brandon is the Co-Founder and CEO at Nava, a modern benefits brokerage on a mission to provide high-quality, affordable access to healthcare to all Americans. By melding cutting-edge tech solutions with deep industry expertise, Nava aims to fix healthcare, one benefits plan at a time.

Prior to Nava, Brandon co-founded VTS, a tech-driven leasing and asset management platform that transformed the commercial real estate marketplace. Trusted by over 45,000 brokers and asset managers around the globe, it’s now used in over 50% of all office buildings in the United States and is consistently ranked one of New York’s best places to work.

Outside of work, he enjoys retreating into nature, and is passionate about backcountry skiing, mountaineering, and trail running.